Articles Mentioning Life Sciences Tools and Services Stocks

Results 61 - 70 of 297 : Previous 3 4 5 6 7 8 9 10 11 Next

Get RSS Feed for Life Sciences Tools and Services

Investing | September 29, 2014

3 Reasons Illumina, Inc.'s Stock Could Fall

Illumina (ILMN) seems unbeatable in sequencing today, but tomorrow could bring changes no one can anticipate.

Investing | September 23, 2014

3 Reasons Illumina, Inc.'s Stock Could Rise

It's the leader in a fast-growing young industry, but does Illumina (ILMN) have what it takes to trounce the market over the long term?

Investing | June 30, 2014

Why Are Companion Diagnostics So Important?

Patients, doctors, and investors have been excited about new frontiers in oncology, but can these drugs be useful without companion diagnostics?

Investing | June 24, 2014

Will Danaher Corporation Bounce Back With a Big Buyout?

M&A's been the biggest trend of health care in 2014, but Danaher's been notably quiet. Will this acquisitions king jump into the game this year?

Investing | April 24, 2014

Illumina, Inc.: How the Market's Smartest Company is Living Up to the Hype

Illumina won rave reviews for its innovative technology after making the $1,000 genome possible, but the company showed off its financial prowess in the first quarter.

Investing | April 23, 2014

Illumina Inc's Seemingly Endless Victory Lap

It's harder to call Illumina overpriced when it continues to surpass bullish expectations and build its lead on rivals

Investing | March 28, 2014

4 Disruptive Stocks Biotechs Depend On

Contract research organizations Quintiles (Q), Icon PLC (ICLR), Covance (CVD), and Parexel (PRXL) are redefining how biopharma discovers and develops new therapies.

Investing | March 21, 2014

1 Great Dividend You Can Buy Right Now

Shareholders in this diagnostics company have witnessed their dividend grow by 340% over the past decade, and that could be just the tip of the iceberg.

Investing | March 06, 2014

3 Reasons to Buy 2014's Smartest Company

Gene sequencing stock Illumina has exploded onto the scene with huge gains for investors, but could the best be yet to come for this exciting company?

Investing | March 03, 2014

PacBio, the Post-Hype Sleeper of Genomics

PacBio, the post-hype sleeper of genomics.

Results 61 - 70 of 297 : Previous 3 4 5 6 7 8 9 10 11 Next

Get RSS Feed for Life Sciences Tools and Services